Cogent Biosciences (COGT) Interest Expenses (2017 - 2026)

Cogent Biosciences (COGT) has 10 years of Interest Expenses data on file, last reported at $6.8 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 170575.0% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $6.8 million, a 170575.0% increase from a year earlier, with the FY2025 full-year figure at $747.2 million, up 241.87% from the prior year.
• Interest Expenses for Q1 2026 stood at $6.8 million, up from $1.3 million in the prior quarter.
• Over the last five years, Interest Expenses for COGT reached as high as $39.0 million in Q2 2022 and fell as low as $4000.0 in Q1 2025.
• Historically, Interest Expenses has averaged $5.2 million across 5 years, with a median of $787500.0 in 2022.
• Across the five-year window, Interest Expenses sank 99.73% in 2023 and surged 170575.0% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $391000.0 in 2022, then jumped by 202.81% to $1.2 million in 2023, then sank by 83.78% to $192000.0 in 2024, then soared by 577.08% to $1.3 million in 2025, then soared by 425.15% to $6.8 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $6.8 million in Q1 2026, $1.3 million in Q4 2025, and $5.8 million in Q3 2025.